NEUROCRINE BIOSCIENCES INC
Total Trades
200
Buys
0
Sells
145
Largest Trade
N/A
Insiders
17
Institutional Funds
622
Inst. Value
$1M+
Activist Filings
13
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| LYONS GARY A | Director | SELL | $500K+ | 5K | $110.06 | Sep 6, 2023 |
| LYONS GARY A | Director | EXERCISE | $50K–$100K | 5K | $12.98 | Sep 6, 2023 |
| Cooke Julie | CHRO | SELL | $50K–$100K | 824 | $110.93 | Sep 6, 2023 |
| Boyer David W. | Chief Corp. Affair… | SELL | $100K–$500K | 3K | $107.60 | Sep 1, 2023 |
| Delaet Ingrid | Chief Regulatory O… | SELL | $100K–$500K | 1K | $107.52 | Aug 30, 2023 |
| ROBERTS EIRY | Chief Medical Offi… | SELL | $100K–$500K | 3K | $107.38 | Aug 24, 2023 |
| Onyia Jude | Chief Scientific O… | SELL | $100K–$500K | 3K | $107.37 | Aug 24, 2023 |
| Lippoldt Darin | Chief Legal Officer | SELL | $100K–$500K | 2K | $107.39 | Aug 24, 2023 |
| GORMAN KEVIN CHARLES | CEO | SELL | $1M+ | 9K | $107.40 | Aug 24, 2023 |
| Gano Kyle | Chief Business Dev… | SELL | $100K–$500K | 2K | $107.41 | Aug 24, 2023 |
| Delaet Ingrid | Chief Regulatory O… | SELL | $100K–$500K | 1K | $107.42 | Aug 24, 2023 |
| Cooke Julie | CHRO | SELL | $100K–$500K | 2K | $107.41 | Aug 24, 2023 |
| Boyer David W. | Chief Corp. Affair… | SELL | $100K–$500K | 2K | $107.41 | Aug 24, 2023 |
| BENEVICH ERIC | Chief Commercial O… | SELL | $100K–$500K | 2K | $107.40 | Aug 23, 2023 |
| ABERNETHY MATT | CFO | SELL | $100K–$500K | 2K | $107.39 | Aug 23, 2023 |
| RASTETTER WILLIAM H | Director | SELL | $100K–$500K | 4K | $101.43 | May 3, 2023 |
| RASTETTER WILLIAM H | Director | EXERCISE | $50K–$100K | 8K | $12.71 | May 3, 2023 |
| Cooke Julie | CHRO | SELL | $1M+ | 11K | $103.89 | May 3, 2023 |
| Cooke Julie | CHRO | SELL | $1K–$15K | 100 | $103.82 | Apr 27, 2023 |
| ROBERTS EIRY | Chief Medical Offi… | SELL | $1M+ | 14K | $103.48 | Apr 27, 2023 |
| RASTETTER WILLIAM H | Director | EXERCISE | $100K–$500K | 12K | $12.71 | Apr 21, 2023 |
| RASTETTER WILLIAM H | Director | SELL | $500K+ | 7K | $105.03 | Apr 21, 2023 |
| Cooke Julie | CHRO | SELL | $1M+ | 17K | $102.76 | Feb 9, 2023 |
| ROBERTS EIRY | Chief Medical Offi… | SELL | $1M+ | 17K | $102.74 | Feb 9, 2023 |
| Onyia Jude | Chief Scientific O… | SELL | $100K–$500K | 5K | $102.30 | Feb 9, 2023 |
| Lloyd-Smith Malcolm | Chief Integration … | SELL | $1M+ | 15K | $102.64 | Feb 9, 2023 |
| Lippoldt Darin | Chief Legal Officer | SELL | $1M+ | 16K | $102.71 | Feb 9, 2023 |
| GORMAN KEVIN CHARLES | CEO | SELL | $1M+ | 29K | $102.90 | Feb 9, 2023 |
| Gano Kyle | Chief Business Dev… | SELL | $1M+ | 17K | $102.79 | Feb 9, 2023 |
| Boyer David W. | Chief Corp. Affair… | SELL | $1M+ | 25K | $102.49 | Feb 9, 2023 |
| BENEVICH ERIC | Chief Commercial O… | SELL | $1M+ | 20K | $102.70 | Feb 9, 2023 |
| ABERNETHY MATT | CFO | SELL | $1M+ | 29K | $102.61 | Feb 9, 2023 |
| ROBERTS EIRY | Chief Medical Offi… | SELL | $100K–$500K | 1K | $109.99 | Feb 2, 2023 |
| Onyia Jude | Chief Scientific O… | SELL | $1K–$15K | 126 | $108.48 | Feb 2, 2023 |
| Lloyd-Smith Malcolm | Chief Integration … | SELL | $100K–$500K | 2K | $110.02 | Feb 2, 2023 |
| Lippoldt Darin | Chief Legal Officer | SELL | $100K–$500K | 1K | $109.97 | Feb 2, 2023 |
| GORMAN KEVIN CHARLES | CEO | SELL | $100K–$500K | 3K | $110.08 | Feb 2, 2023 |
| Gano Kyle | Chief Business Dev… | SELL | $100K–$500K | 2K | $109.98 | Feb 2, 2023 |
| Cooke Julie | CHRO | SELL | $50K–$100K | 916 | $108.48 | Feb 2, 2023 |
| Boyer David W. | Chief Corp. Affair… | SELL | $100K–$500K | 1K | $109.92 | Feb 2, 2023 |
| BENEVICH ERIC | Chief Commercial O… | SELL | $100K–$500K | 1K | $109.95 | Feb 2, 2023 |
| ABERNETHY MATT | CFO | SELL | $100K–$500K | 1K | $109.98 | Feb 2, 2023 |
| BENEVICH ERIC | Chief Commercial O… | EXERCISE | $15K–$50K | 400 | $43.24 | Jan 10, 2023 |
| BENEVICH ERIC | Chief Commercial O… | SELL | $50K–$100K | 400 | $125.00 | Jan 10, 2023 |
| SHERWIN STEPHEN A | Director | SELL | $1M+ | 30K | $118.86 | Jan 5, 2023 |
| SHERWIN STEPHEN A | Director | EXERCISE | $100K–$500K | 30K | $12.85 | Jan 5, 2023 |
| POPS RICHARD F | Director | SELL | $1M+ | 15K | $119.20 | Jan 5, 2023 |
| POPS RICHARD F | Director | EXERCISE | $100K–$500K | 15K | $12.71 | Jan 5, 2023 |
| BENEVICH ERIC | Chief Commercial O… | EXERCISE | $1M+ | 50K | $41.47 | Dec 1, 2022 |
| BENEVICH ERIC | Chief Commercial O… | SELL | $1M+ | 50K | $125.90 | Dec 1, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 622 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| DODGE & COX | 5.5M | $1M+ | SH |
| STATE STREET CORP | 4.2M | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 2.2M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 1.7M | $1M+ | SH |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 1.3M | $1M+ | SH |
| NORGES BANK | 1.1M | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 851K | $1M+ | SH |
| Pictet Asset Management Holding SA | 777K | $1M+ | SH |
| BRAIDWELL LP | 752K | $1M+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 634K | $1M+ | SH |
| Swedbank AB | 584K | $1M+ | SH |
| Swedbank AB | 584K | $1M+ | SH |
| ALLIANCEBERNSTEIN L.P. | 555K | $1M+ | SH |
| PRIMECAP MANAGEMENT CO/CA/ | 508K | $1M+ | SH |
| IEQ CAPITAL, LLC | 505K | $1M+ | SH |
| FIRST TRUST ADVISORS LP | 487K | $1M+ | SH |
| Zurich Insurance Group Ltd/FI | 459K | $1M+ | SH |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 361K | $1M+ | SH |
| PERCEPTIVE ADVISORS LLC | 331K | $1M+ | SH |
| ORBIMED ADVISORS LLC | 314K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G · Jan 21, 2026
5.2%
5.2M shares
SC 13G · May 14, 2025
5.6%
5.5M shares
SC 13G/A · Apr 28, 2025
12.1%
12.1M shares
SC 13G/A · Mar 6, 2025
10.2%
10.1M shares
SC 13G · Feb 5, 2025
4.8%
4.9M shares
STATE STREET CORPORATION 04-2456637
SC 13G · Oct 17, 2024
5.1%
5.1M shares
The Vanguard Group - 23-1945930
SC 13G/A · Feb 13, 2024
9.9%
9.7M shares
SC 13G/A · Jan 23, 2024
13.9%
13.6M shares
SC 13G/A · Jan 23, 2023
13.1%
12.6M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Feb 14, 2022
4.5%
4.4M shares
Janus Henderson Group plc EIN #00-0000000
SC 13G/A · Feb 10, 2022
7.8%
7.4M shares
SC 13G/A · Jan 27, 2022
12.1%
11.5M shares
SC 13G/A · Jan 25, 2022
12.1%
11.5M shares